Core Viewpoint - Truist Financial has set a price target of $400 for Willis Towers Watson PLC, indicating a potential increase of approximately 18.04% from its current stock price of around $338.86 [1][5] Financial Performance - WTW reported a 6% organic revenue growth in Q4 2025, driven by a strategic focus on Risk and Broking, along with investments in talent and innovation [2][5] - The adjusted operating margin increased by 80 basis points to 36.9%, reflecting improved efficiency and profitability [2][5] - The company's adjusted earnings per share rose by 13% year-over-year to $8.12, excluding contributions from TRANZACT, supported by recent acquisitions [3][5] Stock Performance - WTW's stock is currently priced at $337.35, showing a slight increase of 0.67% or $2.25, with fluctuations between $337.05 and $344.99 on the day [4] - Over the past year, the stock reached a high of $352.79 and a low of $292.97, with a market capitalization of approximately $32.91 billion [4]

Key Takeaways WTW posted Q4 adjusted EPS of $8.12, beating estimates as operating margins expanded. Health, Wealth & Career margins jumped 240 bps to 44.3%, aided by organic growth and the TRANZACT sale. Risk & Broking revenues rose 10% year over year, with margin expansion driven by strong organic growth. Willis Towers Watson Public Limited Company (WTW) delivered fourth-quarter 2025 adjusted earnings of $8.12 per share, which beat the Zacks Consensus Estimate by 2.5%. The bottom line increased 2% year ove ...

As a reminder, TRANZACT contributed $0.8 to adjusted EPS in 2024. Excluding this contribution, adjusted EPS increased 13% year over year. For the full year, we had organic growth of 5% in line with our mid-single-digit target. We expanded adjusted operating margin by 130 basis points year over year to 25.2% and delivered adjusted diluted earnings per share of $17.08. In the fourth quarter, health, wealth, and career organic growth accelerated from earlier in the year to 6%, and the segment delivered 30 basi ...

For the quarter ended December 2025, Willis Towers Watson (WTW) reported revenue of $2.94 billion, down 3.3% over the same period last year. EPS came in at $8.12, compared to $8.13 in the year-ago quarter.The reported revenue represents a surprise of +2.51% over the Zacks Consensus Estimate of $2.86 billion. With the consensus EPS estimate being $7.92, the EPS surprise was +2.47%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall ...

Willis Towers Watson (NasdaqGS:WTW) Q4 2025 Earnings call February 03, 2026 09:00 AM ET Company ParticipantsAndrew Andersen - Equity Research SVPAndrew Krasner - CFOBrian Meredith - Managing DirectorCarl Hess - CEOElyse Greenspan - Managing DirectorJulie Gebauer - President of Health, Wealth and CareerLucy Clarke - President of Risk and BrokingMeyer Shields - Managing DirectorRobert Cox - VP of Equity ResearchYaron Kinar - Managing DirectorConference Call ParticipantsDavid Motemaden - Managing Director and ...

Willis Towers Watson (NasdaqGS:WTW) Q4 2025 Earnings call February 03, 2026 09:00 AM ET Company ParticipantsAndrew Andersen - Equity Research SVPAndrew Krasner - CFOBrian Meredith - Managing DirectorCarl Hess - CEOElyse Greenspan - Managing DirectorJulie Gebauer - President of Health, Wealth and CareerLucy Clarke - President of Risk and BrokingMeyer Shields - Managing DirectorRobert Cox - VP of Equity ResearchYaron Kinar - Managing DirectorConference Call ParticipantsDavid Motemaden - Managing Director and ...

Financial Data and Key Metrics Changes - In Q4 2025, the company achieved 6% organic growth, with an adjusted operating margin expansion of 80 basis points, and adjusted EPS of $8.12, reflecting a 13% increase year-over-year when excluding TRANZACT [5][18] - For the full year, organic growth was 5%, with adjusted operating margin expanding by 130 basis points to 25.2%, and adjusted diluted EPS of $17.08, also up 13% year-over-year excluding TRANZACT [5][18] Business Line Data and Key Metrics Changes - Health, Wealth and Career (HWC) segment saw organic growth accelerate to 6% in Q4, with a full-year growth of 4% [5][19] - Risk and Broking (R&B) generated 7% organic growth in Q4, with corporate Risk and Broking achieving 8% growth, marking the 12th consecutive quarter of high single-digit growth [6][25] - The insurance consulting and technology business experienced a decline of 1% in Q4, with full-year growth at 1% compared to 4% the previous year [26] Market Data and Key Metrics Changes - The international market drove growth in the health segment, particularly in Europe, while North America faced challenges due to a book of business sale in the prior year [20] - The company expects strong demand across global markets, driven by healthcare inflation and employers' focus on managing costs while maintaining competitive employee benefits [20][66] Company Strategy and Development Direction - The company is focused on optimizing its portfolio through strategic acquisitions, including Newfront, Cushon, and FlowStone Partners, to enhance growth and profitability [4][15] - The specialization strategy in Risk and Broking continues to drive new business momentum, particularly in construction and surety [6][25] - Investments in talent and technology are central to the company's strategy, with a focus on enhancing efficiency and driving margin expansion [11][33] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position and outlook for 2026, anticipating mid-single-digit organic growth and continued margin expansion [16][30] - The political and regulatory environment remains dynamic, prompting clients to seek the company's advice and solutions [16] - While optimistic about current conditions, management is monitoring potential headwinds for the upcoming year [16] Other Important Information - The company generated free cash flow of $1.5 billion for the year, with a free cash flow margin of 15.9%, an increase from 12.8% the previous year [31] - Share repurchases are a primary method of capital return, with at least $1 billion expected to be allocated to buybacks in 2026 [32] Q&A Session Summary Question: Drivers of organic growth within R&B - Management highlighted strong organic growth of 7% in R&B, driven by specialization strategy and investments in talent, data, and technology [37][39] Question: Mid- to high single-digit guidance for R&B in 2026 - Management acknowledged that while pricing may improve, growth is supported by high retention rates and new business opportunities, particularly in digital infrastructure and electrification [40][42] Question: Impact of talent on organic growth in 2026 - The company plans to continue strategic hiring to support organic growth, emphasizing the importance of talent in driving sustainable and profitable growth [52][54] Question: Changes in Medicare influencing BD&O growth - Management expects modest headwinds from Medicare changes but anticipates strong demand for retiree marketplace services to support low single-digit growth in 2026 [60][61] Question: AI's impact on consulting services - Management views AI as an opportunity rather than a threat, focusing on regulatory-driven recurring services that are expected to remain in demand [74]

February 3, 2026 wtwco.com © 2026 WTW. All rights reserved. WTW Forward-Looking Statements This document contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, which are intended to be covered by the safe harbors created by those laws. These forward-looking statements include information about possible or assumed future results of our operations. All statements, other than statements of historical facts, ...

分组1 - Willis Towers Watson (WTW) reported quarterly earnings of $8.12 per share, exceeding the Zacks Consensus Estimate of $7.92 per share, with a year-over-year comparison showing earnings of $8.13 per share [1] - The company achieved revenues of $2.94 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 2.51%, although this represents a decline from year-ago revenues of $3.04 billion [2] - Over the last four quarters, WTW has surpassed consensus EPS estimates three times and has topped consensus revenue estimates three times as well [2] 分组2 - The stock has underperformed the market, losing about 3.7% since the beginning of the year, while the S&P 500 has gained 1.9% [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $3.61 on revenues of $2.34 billion, and for the current fiscal year, it is $19.24 on revenues of $10.21 billion [7] 分组3 - The Zacks Industry Rank indicates that the Insurance - Brokerage sector is currently in the bottom 13% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8] - The estimate revisions trend for WTW was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold), indicating expected performance in line with the market [6]

EXHIBIT 99.1 WTW Reports Fourth Quarter and Full Year 2025 Earnings LONDON, Feb. 03, 2026 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW) (the "Company"), a leading global advisory, broking and solutions company, today announced financial results for the fourth quarter and full year ended December 31, 2025. "WTW had strong performance across our businesses driven by our team's relentless focus and consistent execution of our strategy" said Carl Hess, WTW's Chief Executive Officer. "We delivered on our financial targe ...